Truist downgraded Cognex from Buy to Hold and set a new price target of $43.00 from $46.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/17/2026 | $68.00 | Hold → Buy | HSBC Securities |
| 12/16/2025 | $50.00 | Sell → Buy | Goldman |
| 12/3/2025 | $35.00 | Neutral → Underweight | Analyst |
| 10/8/2025 | $55.00 | Overweight | Barclays |
| 9/15/2025 | $45.00 | Neutral | Analyst |
| 8/1/2025 | $50.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 7/10/2025 | $60.00 | Hold → Buy | Melius |
| 4/28/2025 | $35.00 | Hold → Buy | TD Cowen |
4 - COGNEX CORP (0000851205) (Issuer)
4 - COGNEX CORP (0000851205) (Issuer)
4 - COGNEX CORP (0000851205) (Issuer)
NATICK, Mass., Feb. 17, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), ("Cognex"), the global technology leader in industrial machine vision, today announced the appointments of Dr. Sami Atiya and Mr. Chris Donato to Cognex's Board of Directors (the "Board"), effective March 2, 2026. "We are excited to welcome Sami and Chris to our Board," said Matt Moschner, President and CEO. "We remain focused on our strategic objectives of becoming the leading provider of AI technology for industrial machine vision, delivering the best customer experience in our industry and doublin
NATICK, Mass., Feb. 11, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, today reported financial results for the fourth quarter and full year 2025. Fourth-Quarter and Full-Year Financial and Operating Highlights Fourth-quarter revenue grew 10% year over year or 9% on a constant-currency basis.Full-year revenue grew 9% year over year or 8% on a constant-currency basis; excluding the one-time benefit from the commercial partnership with a medical lab automation channel partner (the "Commercial Partnership" or "CP"
NATICK, Mass., Feb. 10, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, today announced that its Chief Financial Officer, Dennis Fehr, is scheduled to present at the following upcoming investor conferences: The Barclays 43rd Annual Industrial Select Conference in Miami, Florida on Wednesday, February 18, 2026, at 1:50 p.m. Eastern Standard Time.The Citi 2026 Global Industrial Tech and Mobility Conference in Miami, Florida on Thursday, February 19, 2026, at 8:50 a.m. Eastern Standard Time.The live webcasts and su
8-K - COGNEX CORP (0000851205) (Filer)
10-K - COGNEX CORP (0000851205) (Filer)
8-K - COGNEX CORP (0000851205) (Filer)
HSBC Securities upgraded Cognex from Hold to Buy and set a new price target of $68.00
Goldman upgraded Cognex from Sell to Buy and set a new price target of $50.00
Analyst downgraded Cognex from Neutral to Underweight and set a new price target of $35.00
4 - COGNEX CORP (0000851205) (Issuer)
4 - COGNEX CORP (0000851205) (Issuer)
NATICK, Mass., Feb. 17, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), ("Cognex"), the global technology leader in industrial machine vision, today announced the appointments of Dr. Sami Atiya and Mr. Chris Donato to Cognex's Board of Directors (the "Board"), effective March 2, 2026. "We are excited to welcome Sami and Chris to our Board," said Matt Moschner, President and CEO. "We remain focused on our strategic objectives of becoming the leading provider of AI technology for industrial machine vision, delivering the best customer experience in our industry and doublin
NATICK, Mass., May 29, 2025 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, today announced the appointment of Greer Aviv as Head of Investor Relations, effective June 2, 2025. Ms. Aviv will lead the company's investor relations strategy and communications, serving as the primary liaison between Cognex and the investment community. She will be responsible for articulating the company's vision, financial performance, and strategic direction to shareholders, analysts, and other key stakeholders. Ms. Aviv has an extensi
NATICK, Mass., May 2, 2024 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), a leading provider of machine vision for factory and warehouse automation, today announced the appointment of Dennis Fehr as Senior Vice President of Finance and Chief Financial Officer, effective May 3, 2024. In this role, Fehr will lead Cognex's global finance and information technology organizations. Fehr brings over 20 years of global experience across manufacturing, technology, and energy industries. Most recently, Fehr was the CFO of 6K Inc, a manufacturing technology company focused on strategi
SC 13G - COGNEX CORP (0000851205) (Subject)
SC 13G/A - COGNEX CORP (0000851205) (Subject)
SC 13G/A - COGNEX CORP (0000851205) (Subject)
NATICK, Mass., Feb. 11, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, today reported financial results for the fourth quarter and full year 2025. Fourth-Quarter and Full-Year Financial and Operating Highlights Fourth-quarter revenue grew 10% year over year or 9% on a constant-currency basis.Full-year revenue grew 9% year over year or 8% on a constant-currency basis; excluding the one-time benefit from the commercial partnership with a medical lab automation channel partner (the "Commercial Partnership" or "CP"
NATICK, Mass., Jan. 15, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, will release earnings for the fourth quarter of 2025 on Wednesday, February 11, 2026, after market close. The Company will host a conference call on Thursday, February 12, 2026, at 8:30 a.m. Eastern Standard Time (EST), to discuss the results. Access to the conference call, and a replay that will be available following the call, may be found on the Cognex Investor Relations website at https://www.cognex.com/investor. The telephone number fo
NATICK, Mass., Oct. 29, 2025 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, today reported financial results for the third quarter ended September 28, 2025. Third-Quarter Financial and Operating Highlights Revenue grew 18% year over year or 16% on a constant-currency basis.Excluding the one-time benefit from the commercial partnership with a medical lab automation channel partner (the "Commercial Partnership" or "CP"), revenue grew 13% year over year.Operating margin of 20.9%; Adjusted EBITDA margin of 24.9%, up 730